The most comprehensive evidence comes from three sources: the Phase 2 trial published in the New England Journal of Medicine , the Phase 3 TRIUMPH-4 trial, and a systematic review and meta-analysis that synthesized data from 878 total participants across three randomized controlled trials
Chapters: 00:09 Intro, Rainy Day Banter & Q&A Format Explained 03:10 Why Different Personalities Make the Podcast Work 08:30 Stalled Fat Loss on GLPs & When to Switch Compounds 17:20 Bodyweight Training, Muscle Loss & Metabolism 22:40 Reta Stacks for Fat Loss Without Losing Muscle 31:00 Fasting, Food Timing & Peptide Use 38:20 Vetting Peptide Companies, COAs & Pricing Reality 48:40 TRT, Libido Issues & Estrogen Troubleshooting 57:10 CJC-1295 With vs Without DAC (First-Time Use) 1:00:10 Best Fat Loss Stacks to Run With Reta 1:09:45 SS-31, Mitochondria & Cardiovascular Support 1:11:10 When Surgery Beats Peptides for Healing 1:12:15 Podcast Growth, Future Plans & Outro We cover: Semax & Selank Longevity: BDNF, neuroplasticity, cycling vs continuous use, performance timing, and anxiety dosing strategies Ex-Powerlifter Recomp Plan: TRT + RETA setup, AOD, SLU-PP-332, 5-Amino-1MQ, GH for muscle retention, and how to train heavy for fat loss Training for Body Recomposition: Short rest periods, compound lifts, fasting integration, and hitting muscles twice per week for metabolic output Low-Dose RETA for Women: When to titrate up, why lowest effective dose matters, preserving muscle with Tesa-IPA, and where KPV fits RETA Reality Check: Appetite control vs starvation, habit change, food quality, and why its not a magic shot Thyroid Cancer Warning Explained: Rodent data vs human risk, MEN2 history, quality-of-life decision making, and doctor conversations that matter What to Stack with RETA: Fat-loss stacks vs mitochondria, anti-aging protocols, NAD timing, and GH for 40+ optimization Long-Term Low-Dose RETA: Metabolic health benefits, desensitization myths, titrating down vs coming off, and maintenance strategy Endurance Athletes & Fueling Issues: When RETA suppresses calories too much, MK-677/IPA for appetite, GH timing, and recovery support Peptide Safety & Contamination: China raws vs U.S
Every effort was made to minimize the number of mice used in the experiments and their suffering
However, drugs that are in shortage are not considered by the Food and Drug Administration (FDA) to be commercially available
Regular follow-ups allow your provider to review your progress and make necessary adjustments
if they continue to do well, the drainage tubes in their chest can then be removed and they can be moved to a regular hospital bed later that day
